NLRP3 and cardiac hypertrophy: Finally, the molecular mechanism of miR-26a-5p regulating autophagy leading to NLRP3 inflammasome activation was further explored, and the potential clinical value of miR-26a-5p molecule as a diagnostic and therapeutic target for cardiac hypertrophy was elucidated.